Journal Article DZNE-2020-00354

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Impact of atrial fibrillation burden on cognitive function after left atrial ablation - Results of the MACPAF study.

 ;  ;  ;  ;  ;  ;  ;

2020
Harcourt Burlington, Mass.

Journal of clinical neuroscience 73, 168-172 () [10.1016/j.jocn.2019.12.030]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Atrial fibrillation (AF) is associated with cognitive decline and dementia irrespective of AF-related ischemic stroke. We investigated whether AF burden after ablation in patients with symptomatic paroxysmal AF has an impact on cognitive function. After enrolment to the prospective MACPAF study, study patients received an insertable loop recorder (ILR) and underwent serial neurological/cognitive assessment. To compare cognitive function, the delta of baseline and six months test results (Δpre/post) and a score to assess overall cognitive performance were computed. Thirty patients (median age 65 years (IQR 57-69), 40% female) were divided into groups according to median AF burden (<0.5% vs. ≥0.5%) after ablation. Overall cognitive performance did not differ in patients with an AF burden < 0.5% (median 120% [IQR 100-150]) vs. ≥0.5% (median 120% [IQR 100-160]) within six months after ablation (p = 0.74). Comparing Δpre/post, patients with an AF burden ≥ 0.5% showed significantly better results in the digit-span backwards test (median + 1 [IQR 0 - +2 points]) compared to patients with an AF burden < 0.5% (median 0 [IQR -1-+1]) six months after ablation (p = 0.03). In patients with an AF burden < 0.5%, there was a statistical trend towards better results in the RAVLT test (median + 3 [IQR 0-+4]; p = 0.08) and the ROC test (median + 3 [IQR -1-+5; p = 0.07) compared to patients with an AF burden ≥ 0.5% (median -1 [IQR -3-+2] words and median -1 [IQR -5-+2] points, respectively). Therefore, AF burden had no significant impact on cognitive performance within six months after ablation. Clinical Trial Registration: clinicaltrials.gov NCT01061931.

Keyword(s): Aged (MeSH) ; Atrial Fibrillation: complications (MeSH) ; Atrial Fibrillation: physiopathology (MeSH) ; Atrial Fibrillation: surgery (MeSH) ; Catheter Ablation: methods (MeSH) ; Cognition (MeSH) ; Cognition Disorders: epidemiology (MeSH) ; Cognition Disorders: etiology (MeSH) ; Female (MeSH) ; Humans (MeSH) ; Male (MeSH) ; Middle Aged (MeSH) ; Prospective Studies (MeSH) ; Treatment Outcome (MeSH)

Classification:

Contributing Institute(s):
  1. Interdisciplinary Dementia Research (AG Endres)
Research Program(s):
  1. 344 - Clinical and Health Care Research (POF3-344) (POF3-344)

Appears in the scientific report 2020
Database coverage:
Medline ; Clarivate Analytics Master Journal List ; Essential Science Indicators ; IF < 5 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > B DZNE > B DZNE-AG Endres
Public records
Publications Database

 Record created 2020-07-10, last modified 2025-07-17


Fulltext:
Download fulltext PDF Download fulltext PDF (PDFA)
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)